GlassScriptPhysician profile
Maxx Caveney
NPI 1528591617
$5,562.19
in general payments reported to CMS, 2019-2025
30 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $371 · 2023: $1,097 · 2024: $2,737 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,090 · Travel and Lodging: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,090.08 |
| Travel and Lodging | $986.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $978.11 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $784.20 | 2022-2024 | Ams 700, Ams 800 Artificial Urinary Sphincter, Moses 550 D\F\L |
| Axonics, INC. | $565.76 | 2024 | Bulkamid, Axonics |
| Medtronic, INC. | $445.72 | 2024-2025 | Interstim |
| Abbvie INC. | $377.99 | 2023-2025 | Botox |
| Sumitomo Pharma America, INC. | $268.24 | 2023-2025 | Orgovyx |
| Urogen Pharma, INC. | $235.34 | 2023-2025 | Jelmyto |
| Calyxo, INC. | $182.01 | 2024 | Cvac Aspiration System |
| Olympus America INC. | $174.24 | 2024-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $166.49 | 2024-2025 | Provenge |
| Janssen Biotech, INC. | $163.74 | 2024-2025 | Erleada, Akeega |
| Myriad Genetic Laboratories, INC. | $133.29 | 2023-2024 | Prolaris |
| Coloplast Corp | $129.24 | 2023 | Titan |
| Verity Pharmaceuticals INC. | $128.03 | 2024-2025 | Trelstar, Tlando |
| Baxter Healthcare | $114.53 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $112.33 | 2025 | Xiaflex |
| Innovation Technologies INC | $109.15 | 2023 | Irrisept |
| Immunitybio, INC. | $93.64 | 2025 | |
| Merck Sharp & Dohme LLC | $80.40 | 2024 | Lynparza, Welireg, Keytruda |
| Blue Earth Diagnostics | $48.27 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.35 | 2025 | |
| Davol INC. | $42.47 | 2025 | Arista |
| Steris Corporation | $37.31 | 2024 | |
| Progenics Pharmaceuticals, INC. | $35.47 | 2024-2025 | |
| Tolmar, INC. | $32.52 | 2024-2025 | Jatenzo, Eligard |
| Laborie Medical Technologies Corp. | $24.61 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Civco Medical Instruments | $19.07 | 2024 | |
| Photocure INC | $15.62 | 2024 | Cysview |
| Accord Healthcare, INC. | $14.44 | 2024 | |
| Mission Pharmacal Company | $6.61 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxx Caveney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.